Georgia CEAL RESTORES Family Diabetes Study
GA CEAL
Community Engaged Alliance-Reimagined Environments and Systems Together for Outcomes Georgia Through Research and Evaluation for Sustainability (RESTORES) - Georgia CEAL RESTORES
2 other identifiers
interventional
120
1 country
1
Brief Summary
The goal of this clinical trial is to determine whether a family-based lifestyle intervention reduces the risk of type 2 diabetes (T2D) among parents and their children. The intervention will also evaluate how well the program supports healthy lifestyle behaviors and family engagement. The primary outcome of this study is weight loss in parents. Researchers will evaluate changes in participants' weight and lifestyle behaviors before the study compared to the end of the study (12 weeks post intervention) and 3 months after participation in the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 29, 2026
CompletedFirst Submitted
Initial submission to the registry
September 2, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
September 18, 2026
September 1, 2026
1.5 years
September 2, 2026
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Reduction
Weight at 12 weeks (post intervention) and three month follow up
From enrollment to the end of intervention at 6 months
Study Arms (1)
Single arm pre/post study
EXPERIMENTALInterventions
A weekly lifestyle modification program for families with at least one parent at high risk of developing diabetes.
Eligibility Criteria
You may qualify if:
- Parent/guardian must identify as African American or Hispanic
- Parent/guardian must be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child)
- Parent/guardian must have prediabetes (HbA1c level 5.7-6.4%) or be at risk of developing Type 2 diabetes using CDC's Pre-Diabetes Risk Test
- Participant is willing to commit to participation in a 12-week, in-person, intervention study
- No plans to move over the next 9-months
- Parent/guardian should be ambulatory and able to participate in physical activity
- Children must be between the ages of 12-17 years old
- Child should be ambulatory and able to participate in physical activity
You may not qualify if:
- Severe psychological disorders that may prevent/interfere with study -participation
- Physical impairments that may prevent participation in moderate intensity physical activity
- Previous diagnosis of diabetes
- History of congestive heart failure
- Renal failure
- Recent (\<12 months) cardiovascular events such as myocardial infarction (heart attack) or stroke
- Taking medications that may affect endpoint analyses
- Have co-morbid contraindications to physical activity or dietary changes
- Currently pregnant or planning to become pregnant in the next year
- Family lives outside of Georgia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Morehouse School of Medicine
Atlanta, Georgia, 30310, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rakale C Quarells, PhD
Morehouse School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 2, 2026
First Posted
September 9, 2026
Study Start
August 29, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
September 18, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data are shared with the NIH CEAL Network biannually.
- Access Criteria
- Members of the NIH CEAL Network will have access based on the data use agreements in place.
De-identified individual data will be shared with the NIH CEAL National Network.